• T7 RNA Polymerase for RNA Production Workflows

  2026-09-25

  Use T7 RNA Polymerase to generate defined RNA from promoter-bearing DNA templates, then carry that controlled input into structural, functional, or delivery studies. This guide connects practical in vitro transcription choices with research on lipid nanoparticle trafficking—while distinguishing RNA production from the separate challenge of intracellular delivery.

• From BOP Coupling to Smarter Prodrug Research

  2026-09-25

  A translational perspective on how coupling chemistry can support prodrug research—without confusing a useful synthesis tool with evidence of therapeutic performance. We examine the ROS-responsive, carrier-free triterpene strategy reported for oral squamous cell carcinoma, the questions it raises for researchers, and where BOP reagent may fit in exploratory molecular construction.

• Cy7 NHS Ester: Practical Labeling and QC Guide

  2026-09-24

  Sulfo-Cy7 NHS Ester is a water-soluble near-infrared dye for labeling proteins and peptides through accessible amino groups, supporting conjugate preparation for near-infrared fluorescent imaging. Use it when an aqueous labeling workflow is useful; it is not suitable for targets without accessible primary amines, and prepared dye solutions should be used promptly rather than stored long term.

• Ridaforolimus Workflows for mTOR Cancer Research

  2026-09-24

  Use Ridaforolimus to connect mTOR target engagement with cell-growth and angiogenesis readouts in cancer models. This workflow separates direct pathway effects from downstream phenotypes—and clearly distinguishes mTOR research from senolytic discovery.

• Molidustat (BAY85-3934) Workflows for HIF Research

  2026-09-23

  Molidustat provides a controllable way to study PHD-dependent HIF stabilization and endogenous erythropoietin signaling, with practical workflows for renal-anemia models and oxygen-sensing assays. Its use alongside a Septin4–VHL cardiomyocyte study can help distinguish changes in HIF regulation, but does not establish a treatment effect in heart cells.

• Ibotenic Acid: NMDA Agonist Workflow

  2026-09-23

  Use Ibotenic acid to connect glutamatergic circuit activation with behavioral, biochemical, and neuronal injury readouts in controlled preclinical studies. This workflow emphasizes time-resolved sampling, formulation discipline, and interpretation of dose-dependent toxicity data so researchers can build more reproducible neuroscience assays.

• Calpain Inhibitor I, ALLN: Lab Guide

  2026-09-22

  Calpain Inhibitor I, ALLN (SKU A2602) provides an experimental way to inhibit calpain I, calpain II, and selected cathepsins in apoptosis, inflammation, and ischemia-reperfusion workflows. It should be used with vehicle, viability, and pathway controls rather than treated as a calpain-specific diagnostic, therapeutic, or stand-alone mechanistic probe.

• (+)-Bicuculline: Practical Protocol & QC

  2026-09-22

  This guide explains how to prepare, store, and apply (+)-Bicuculline as a GABAA receptor antagonist in neuronal and synaptic signaling workflows. It is a research reagent only; the dossier-supported in vivo context should not be treated as a clinical, diagnostic, or universal dosing protocol.

• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-09-21

  The HyperScribe All in One mRNA Synthesis Kit combines T7 transcription, co-transcriptional ARCA capping, DNase treatment, and enzymatic poly(A) tailing for translation-ready mRNA. Its unified workflow supports mRNA vaccine synthesis, in vitro translation mRNA preparation, antisense RNA synthesis, and RNA interference experiments while keeping RNA production distinct from delivery-system optimization.

• Molidustat (BAY85-3934) for Renal Anemia

  2026-09-21

  Molidustat (BAY85-3934) is a HIF prolyl hydroxylase inhibitor that stabilizes hypoxia-inducible factor signaling and supports endogenous erythropoietin research. Its reported isoform IC50 values, oxygen-sensing mechanism, CKD-anemia relevance, and formulation limits define a practical translational profile.

• G-1: Selective GPR30 Agonist

  2026-09-20

  G-1 is a selective GPR30 agonist for studying rapid GPER1 signaling without substantial classical ERα or ERβ engagement. Product and preclinical evidence supports applications in cardiovascular models, breast cancer cell migration, and receptor-defined neuroscience workflows.

• Tacalcitol Monohydrate: A Response-First Guide

  2026-09-19

  Tacalcitol monohydrate is a synthetic analog of vitamin D3 with applications spanning keratinocyte biology, NGF induction, and colorectal cancer research. This evidence-led guide explains how to select endpoints, interpret VDR-dependent responses, and design studies combining tacalcitol with 5-fluorouracil.

• EZ Cap EGFP mRNA 5-moUTP Workflow Guide

  2026-09-18

  Learn how to use EZ Cap EGFP mRNA 5-moUTP as a reproducible fluorescent benchmark for transfection, translation, cell viability, and delivery studies. The workflow connects Cap1 and 5-moU chemistry with practical LNP screening, including lessons from machine-learning-guided microglia research.

• Molidustat and the HIF Oxygen-Sensing Opportunity

  2026-09-18

  Molidustat (BAY85-3934) offers a mechanistically precise way to study HIF-PH inhibition, endogenous erythropoietin stimulation, and chronic kidney disease anemia. This thought-leadership perspective connects its renal anemia research potential with the Septin4–VHL–HIF-1α axis, while defining practical validation steps and translational limits.

• Z-VAD-FMK Workflows for Apoptosis Research

  2026-09-17

  Z-VAD-FMK enables controlled testing of whether a cell-death phenotype depends on caspase signaling, with practical value in immune-cell, transcriptional-stress, and cancer research models. This guide combines workflow design, assay interpretation, storage guidance, and troubleshooting for more defensible apoptosis inhibition experiments.

8574 records 1/572 page Next 12345 下5页 Last page